Search results for "Press"

showing 10 items of 15058 documents

Strength and power changes of the human plantar flexors and knee extensors in response to resistance training in old age

2002

Aim: The aim of the present study was to assess and compare the improvements of muscle strength and power induced by a 16-week resistive programme in a population of 16 older men aged 65-81 years. Methods: Training was performed three times per week at an intensity of 80% of one repetition maximum (1RM) and consisted of both calf raise and leg press exercises. Before-, during- and after-training, maximum isometric and isokinetic torques, maximum power, 1RM, muscle cross-sectional area (CSA) and electromyographic activity (EMG) of the plantar flexors (PF) and knee extensors (KE) were examined. Results: For the KE and PF, respectively, training resulted in a 29.9 ± 4.4% (mean ± SE) and 21.6 ±…

medicine.medical_specialtyeducation.field_of_studyPhysiologyStrength trainingbusiness.industryPopulationIsometric exerciseCoactivationMuscle hypertrophyInternal medicineOne-repetition maximummedicineCardiologyPhysical therapyExercise physiologyLeg presseducationbusinessActa Physiologica Scandinavica
researchProduct

Calidad de vida relacionada con la salud en personas con hipertensión y diabetes mellitus

2021

Objetivo: Determinar los factores sociodemográficos y clínicos asociados a la Calidad de Vida relacionada con la salud (CVRS) en personas con hipertensión arterial y diabetes mellitus tipo 2.Métodos: Estudio analítico de corte transversal en una muestra de 184 usuarios de un programa de control de riesgo cardiovascular en Bucaramanga (Colombia). Se utilizó el instrumento EQ-5D-3L para evaluar la calidad de vida. Un modelo de regresión lineal múltiple fue llevado a cabo usando como desenlace la Escala Visual Análoga y como posibles predictores las dimensiones del EQ-5D, ajustando por edad, sexo, grupo de intervención (variable instrumental) y variables clínicas como la patología de base y el…

medicine.medical_specialtyeducation.field_of_studyVisual analogue scalebusiness.industryPopulationType 2 Diabetes MellitusType 2 diabetesDiseasemedicine.diseaseBlood pressureQuality of lifeInternal medicinemedicineeducationbusinessSocioeconomic statusGeneral NursingEnfermería Global
researchProduct

Depression and its correlation with the risk of cardiovascular mortality in primary care population in Latvia

2016

IntroductionDepression is one of several preventable causes of disability worldwide, with coronary heart disease (CHD) being the largest cause of disability. Depression has been confirmed as a risk factor for CHD.ObjectivesFew studies tried to find an interrelation between depression and a risk of cardiovascular mortality according to systematic coronary risk evaluation (SCORE) chart.AimsThe aim of study was to examine the correlation of depression with the risk of cardiovascular mortality (SCORE).MethodsStudy was conducted in 2015 within the framework of National Research Programme BIOMEDICINE. All patients aged 18 and older at 24 primary care facilities were interviewed with a sociodemogr…

medicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationOdds ratioLogistic regressionCorrelationPsychiatry and Mental healthBlood pressureInternal medicinemedicinePhysical therapyRisk factorbusinesseducationDepression (differential diagnoses)Mini-international neuropsychiatric interviewEuropean Psychiatry
researchProduct

Subtypes of Depression: Latent Class Analysis in Spanish Old People with Depressive Symptoms

2020

Major depressive disorder (MDD) is one of the most disabling disorders and the one that most contributes to disability. When it occurs in older people, it is an additional burden to their potential physical and cognitive deficiencies, making MDD an important public health problem that supposes a large investment in health. There is a clear lack of consistency between the subtypes of depression found in the literature, ranging from two to seven classes, with three being the most commonly found non-melancholic, melancholic and psychotic, or putative psychotics. The aim of this research is to add knowledge to the profiles of depressive symptoms in a representative sample of older Spanish peopl…

medicine.medical_specialtyelderlyArticleGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineQuality of life (healthcare)medicinelcsh:ScienceEcology Evolution Behavior and SystematicsDepressive symptomsDepression (differential diagnoses)major depressive disorderPublic healthPaleontologyCognitionmedicine.diseaseLatent class model030227 psychiatrySymptom profilesquality of lifeSpace and Planetary ScienceMajor depressive disorderlcsh:QErratumPsychology030217 neurology & neurosurgeryClinical psychologyLife
researchProduct

Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a ce…

2021

Purpose: Metformin induces GLUT-4 mRNA expression in insulin target tissues in PCOS. It is unclear how long this impact is sustained after withdrawal of metformin. We aimed to compare the effect of metformin withdrawal on GLUT-4 mRNA expression in subcutaneous adipose tissue after prior short (ST, 1 year, N = 11) and long term (LT, at least 3 years, N = 13) treatment in obese PCOS women. Methods: At baseline and 6 months after withdrawal, biopsy of subcutaneous adipose tissue followed by quantitative PCR analysis was performed to determine GLUT-4 mRNA expression. Results: We found no time/effect differences in GLUT-4 mRNA expression in ST (2-dCt at baseline 0.42 (0.16–0.48) vs 2-dCt after 6…

medicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMrna expressionGlucose Transport Proteins FacilitativeSubcutaneous FatAdipose tissueQuantitative PCR analysisEndocrinologyInternal medicineBiopsymedicineHumansRNA MessengerAdipose tissue GLUT-4 mRNA Metformin PCOS Adipose Tissue Female Humans RNA Messenger Subcutaneous Fat Metformin Polycystic Ovary Syndromemedicine.diagnostic_testbusiness.industryInsulinGlucose transporternutritional and metabolic diseasesMetforminMetforminEndocrinologyAdipose TissueFemaleSubcutaneous adipose tissuebusinessPolycystic Ovary Syndromemedicine.drug
researchProduct

Increased Connexin 43 Expression as a Potential Mediator of the Neuroprotective Activity of the Corticotropin-Releasing Hormone

2009

CRH is a major central stress mediator, but also a potent neuroprotective effector. The mechanisms by which CRH mediates its neuroprotective actions are largely unknown. Here, we describe that the gap junction molecule connexin43 (Cx43) mediates neuroprotective effects of CRH toward experimentally induced oxidative stress. An enhanced gap junction communication has been reported to contribute to neuroprotection after neurotoxic insults. We show that CRH treatment up-regulates Cx43 expression and gap junctional communication in a CRH receptor-dependent manner in IMR32 neuroblastoma cells, primary astrocytes, and organotypic hippocampal slice cultures. MAPKs and protein kinase A-cAMP response…

medicine.medical_specialtyendocrine systemCorticotropin-Releasing HormoneMAP Kinase Signaling SystemCarbenoxoloneConnexinBiologyNeuroprotectionModels BiologicalArticleRats Sprague-DawleyCorticotropin-releasing hormoneMiceEndocrinologyMediatorInternal medicineCell Line Tumormedicinepolycyclic compoundsAnimalsHumansProtein kinase AMolecular BiologyGap junctionBrainGap JunctionsGeneral MedicineCell biologyRatsEndocrinologyNeuroprotective Agentsnervous systemGene Expression RegulationConnexin 43cardiovascular systemSignal transductionhormones hormone substitutes and hormone antagonistsmedicine.drugSignal Transduction
researchProduct

Controlled Ovarian Stimulation Induces a Functional Genomic Delay of the Endometrium with Potential Clinical Implications

2008

Context: Controlled ovarian stimulation induces morphological, biochemical, and functional genomic modifications of the human endometrium during the window of implantation. Objective: Our objective was to compare the gene expression profile of the human endometrium in natural vs. controlled ovarian stimulation cycles throughout the early-mid secretory transition using microarray technology. Method: Microarray data from 49 endometrial biopsies obtained from LH+1 to LH+9 (n = 25) in natural cycles and from human chorionic gonadotropin (hCG) +1 to hCG+9 in controlled ovarian stimulation cycles (n = 24) were analyzed using different methods, such as clustering, profiling of biological processes…

medicine.medical_specialtyendocrine systemEndocrinology Diabetes and Metabolismmedia_common.quotation_subjectClinical BiochemistryStimulationLuteal PhaseBiologyEndometriumChorionic GonadotropinBiochemistryHuman chorionic gonadotropinEndometriumEndocrinologyOvulation InductionReference ValuesInternal medicinemedicineHumansMenstrual CycleMenstrual cycleOligonucleotide Array Sequence Analysismedia_commonRegulation of gene expressionGlutathione PeroxidaseGenome HumanReverse Transcriptase Polymerase Chain ReactionMicroarray analysis techniquesurogenital systemBiochemistry (medical)Luteinizing HormoneInsulin-Like Growth Factor Binding ProteinsGene expression profilingInsulin-Like Growth Factor Binding Protein 3Endocrinologymedicine.anatomical_structureGene Expression RegulationGene chip analysisRNAFemaleAlgorithms
researchProduct

Cortisol suppression and hearing thresholds in tinnitus after low-dose dexamethasone challenge

2012

Abstract Background Tinnitus is a frequent, debilitating hearing disorder associated with severe emotional and psychological suffering. Although a link between stress and tinnitus has been widely recognized, the empirical evidence is scant. Our aims were to test for dysregulation of the stress-related hypothalamus-pituitary adrenal (HPA) axis in tinnitus and to examine ear sensitivity variations with cortisol manipulation. Methods Twenty-one tinnitus participants and 21 controls comparable in age, education, and overall health status but without tinnitus underwent basal cortisol assessments on three non-consecutive days and took 0.5 mg of dexamethasone (DEX) at 23:00 on the first day. Corti…

medicine.medical_specialtyendocrine systemHearing lossAudiologyStressCortisol03 medical and health sciencesTinnitus0302 clinical medicineMineralocorticoid receptorGlucocorticoid receptorotorhinolaryngologic diseasesMedicineDexamethasone030304 developmental biology0303 health sciencesAbsolute threshold of hearingbusiness.industryHPA axisHearing thresholdlcsh:OtorhinolaryngologyHearing sensitivityLow-dose dexamethasone suppression testlcsh:RF1-547Hearing disorderOtorhinolaryngologyDexamethasone suppression testmedicine.symptombusiness030217 neurology & neurosurgeryTinnitushormones hormone substitutes and hormone antagonistsResearch Articlemedicine.drugBMC Ear, Nose and Throat Disorders
researchProduct

Atrial natriuretic peptide secretion during development of the rat supraoptic nucleus

2009

Since a relationship between atrial natriuretic peptide and oxytocin was recently demonstrated in the heart (Gutkowska et al., 1997), the aim of this study was to determine whether a relationship between the two peptides is present also in the rat hypothalamus. For this purpose, we measured ANP-ontogeny in the rat hypothalamus immunohistochemically and compared it with oxytocin-ontogeny which we previously studied. The results showed that the ANP-peptide and mRNA-ANP start at the 18th day of the fetal life. Our earlier data for oxytocin in the rat hypothalamus showed that only mRNA-oxytocin appeared the 18th day of foetal life (Farina Lipari et al., 2001); thus, at the 18th day of foetal li…

medicine.medical_specialtyendocrine systemHistologyBiophysicsOxytocinSupraoptic nucleusAtrial natriuretic peptidePregnancyInternal medicinesupraopticMedicineAnimalsSecretionRNA MessengerRats Wistarlcsh:QH301-705.5FetusMessenger RNAbusiness.industryReverse Transcriptase Polymerase Chain ReactionnucleushypothalamicCell BiologyImmunohistochemistryRatsEndocrinologyOxytocinAnimals NewbornGene Expression Regulationlcsh:Biology (General)Hypothalamuscardiovascular systemFemalebusinessSupraoptic NucleusAtrial Natriuretic FactorCell Nucleolushormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologymedicine.drugEuropean Journal of Histochemistry
researchProduct

Myogenic effects enhance norepinephrine constriction: Inhibition by nitric oxide and felodipine

1998

Myogenic effects enhance norepinephrine constriction: Inhibition by nitric oxide and felodipine. Myogenic, pressure-induced vasoconstriction may amplify the effects of circulating vasoconstrictors. Through intravital microscopy in cremaster arterioles (31 to 115 μm diameter), the relative contribution of myogenic responses (MR) to norepinephrine (NE)-induced constriction and the inhibitor potency of nitric oxide (NO) or a Ca2+ entry blocker (CEB), felodipine (F), were examined. In 24 anesthetized hamsters, a vessel occluder was placed around the aorta to control cremaster vessel inflow pressure (IP). NE infusion increased blood pressure (by 50 ± 2mm Hg) and induced significant constriction …

medicine.medical_specialtyendotheliumVasodilator AgentsmicrocirculationMyogenic mechanismBayliss effectBlood PressureNitric OxideNitroarginineMuscle Smooth VascularConstrictionNitric oxideMicrocirculationNorepinephrine (medication)Norepinephrinechemistry.chemical_compoundCricetinaeInternal medicineintravital microscopymedicineAnimalsVasoconstrictor AgentsBayliss effectAorta AbdominalcremasterFelodipineCapillariesArteriolesEndocrinologychemistryFelodipineNephrologyAnesthesiacalcium entry blockerInjections Intravenouscardiovascular systemmedicine.symptomVasoconstrictionmedicine.drugKidney International
researchProduct